U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07211984) titled 'Evaluation of Dalia Solution For Depressed Patient' on Oct. 01.
Brief Summary: The goal of this superiority clinical investigation, prospective, multicenter, controlled, randomized, open-label is to evaluate the clinical impact of the Dalia medical telemonitoring device on the management of depressive patients. The main question it aims to answer is: the percentage of patients with clinically significant improvement at 3 months. A clinically significant improvement is defined as a decrease of at least 5 points from the initial PHQ-9 score AND/OR a PHQ-9 score lower than 15. The threshold of 5 points is the Minimal Clinically Importan...